- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01753258
Outcomes of Delivery in Patients With Dyspareunia
October 10, 2016 updated by: Hadassah Medical Organization
Outcomes of Delivery in Patients With Dyspareunia- A Prospective Study
The focus of this pilot study is to determine if a woman who experiences pain during sexual intercourse has a higher risk of complications during labor and delivery secondary to pelvic floor dysfunction, anxiety and intolerance towards pelvic examinations.
Furthermore, it is unclear whether women with prepartum dyspareunia experience an improvement following vaginal delivery.
While physicians may expect that vaginal birth improves dyspareunia due to the stretching effect on pelvic floor, to date, there is insufficient evidence to support this claim.
The Investigators plan to prospectively study 200 patients at our Institution, collect information regarding birth and follow them, via questionnaires, regarding their dyspareunia postpartum.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
173
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jerusalem, Israel
- Hadassah Medical Organization
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Nulliparous women admitted to the Labor and Delivery Department at the Hadassah Medical Center, above the age of 18
Description
Inclusion Criteria:
- 200 nulliparous women admitted to the Labor and Delivery Department at the Hadassah Medical Center, above the age of 18.
- Able and willing to read, understand, and sign the Informed Consent Form and questionnaire.
- Agree to be contacted in the future to complete telephone questionnaires.
Exclusion Criteria:
- Induction of labor
- Placental abruption, placenta previa
- Malpresentation
- Non reassuring fetal heart rate upon admission
- Any other contraindication for vaginal delivery
- Multifetal pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Definite diagnosis of dyspareunia
Patients who report dyspareunia, and whose dyspareunia was evaluated prior to delivery by a caregiver experienced with sexual pain disorders, with definite diagnosis.
|
No definite diagnosis of dyspareunia
Patients who report dyspareunia but were not evaluated prior to delivery or were evaluated inappropriately (i.e.
"yeast infection" without cultures, "inflammation" and other vague definitions).
|
Patients without dyspareunia
Patients without dyspareunia- those who report non painful sexual intercourse.
This group of patients will be used as a control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Obstetrical outcome of women with a history of dyspareunia
Time Frame: 3 months -1 year
|
The Investigators will record the mode of delivery (vaginal, instrumental or cesarean section), length of the second stage of labor, use of anesthetics, perineal tears and\or episiotomies, and newborn's birth weight.
The evaluation will be done prospectively, comparing data with matched controls without a history of dyspareunia.
|
3 months -1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Rate of alleviation of dyspareunia following vaginal delivery as assessed through patient questionnaires.
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (ACTUAL)
September 1, 2016
Study Completion (ACTUAL)
September 1, 2016
Study Registration Dates
First Submitted
December 12, 2012
First Submitted That Met QC Criteria
December 17, 2012
First Posted (ESTIMATE)
December 20, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
October 11, 2016
Last Update Submitted That Met QC Criteria
October 10, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Delivery-Dyspareunia-HMO-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Turku University HospitalUniversity of TurkuCompleted
-
Hopital Antoine BeclereUnknown
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium